A Look to the Future
Inspite of substantial research, the rate of morbidity and mortality for subarachnoid hemorrhage has not changed significantly in the past decade. Unfortunately, recent pharmacological treatments have not demonstrated improved outcomes.
However, improved individual outcomes may be possible through increased public and professional awareness of risk reduction, recognition of warning signs, prompt diagnosis, appropriate referral and preventative treatment of known aneurysms. Prevention of rebleeding as well as an improved understanding of the pathogenesis and treatment of cerebral vasospasm will likely remain research priorities.
ClinicalTrials.gov provides a list of SAH related research studies.